Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)

Historic Tax Provisions for Revolution Medicines (RVMD) over the last 4 years, with Q4 2024 value amounting to -$800000.0.

  • Revolution Medicines' Tax Provisions fell 33323.62% to -$800000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$800000.0, marking a year-over-year increase of 7729.85%. This contributed to the annual value of -$800000.0 for FY2024, which is 7729.85% up from last year.
  • Per Revolution Medicines' latest filing, its Tax Provisions stood at -$800000.0 for Q4 2024, which was down 33323.62% from $343000.0 recorded in Q4 2023.
  • Revolution Medicines' Tax Provisions' 5-year high stood at $362000.0 during Q4 2020, with a 5-year trough of -$3.9 million in Q3 2023.
  • Moreover, its 4-year median value for Tax Provisions was -$210000.0 (2022), whereas its average is -$639375.0.
  • Data for Revolution Medicines' Tax Provisions shows a peak YoY increase of 37886.18% (in 2023) and a maximum YoY decrease of 120202.02% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows Revolution Medicines' Tax Provisions stood at $362000.0 in 2020, then tumbled by 133.98% to -$123000.0 in 2022, then soared by 378.86% to $343000.0 in 2023, then crashed by 333.24% to -$800000.0 in 2024.
  • Its Tax Provisions was -$800000.0 in Q4 2024, compared to $343000.0 in Q4 2023 and -$3.9 million in Q3 2023.